Login
$GH
$147.54 +$3.51 (2.44%) After hours

$GH SEC Filings

Filed On Filing
16 Nov 2026 144
16 Nov 2026 144
13 Nov 2026 Form 4: Azar Alex M Ii, Director

Received 138 shares by exercise or conversion

13 Nov 2026 Form 4: Sayer Kevin R, Director

Granted 3,149 Restricted Stock Units

12 Nov 2026 Form 3: Sayer Kevin R, Director

Holds 0 shares of Common Stock

12 Nov 2026 Form 4: Parks Robert, Chief Accounting Officer

Granted 18,893 Restricted Stock Units

12 Nov 2026 Form 3: Parks Robert, Chief Accounting Officer

Holds 0 shares of Common Stock

05 Nov 2026 10-Q
05 Nov 2026 8-K: Results of Operations and Financial Condition

Third quarter 2026 revenue growth of 36% driven by strong performance in Oncology and Screening

05 Nov 2026 SCHEDULE 13G
03 Nov 2026 8-K: Departure/Election of Directors or Officers; Compensation

PALO ALTO, Calif., — November 3, 2026 — Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the appointment of Kevin Sayer to its board of directors. Mr. Sayer is former CEO of Dexcom, Inc. and curre...

03 Nov 2026 8-K: Departure/Election of Directors or Officers; Compensation

Guardant Health, Inc., a Delaware corporation (the “Company”), has granted to the participant listed below (“Participant”) the Performance-Based Restricted Stock Units (the “PSUs”) described in this Global Performance-Based Restricted St...

22 Oct 2026 Form 4: Mignone Roberto, Director

Received 264 shares by exercise or conversion

19 Oct 2026 Form 4: Hidalgo Medina Manuel, Director

Received 232 shares by exercise or conversion

19 Oct 2026 Form 4: Tariq Musa, Director

Received 250 shares by exercise or conversion · Sold 116 shares ($19.2K)

16 Oct 2026 144
15 Oct 2026 Form 4: Azar Alex M Ii, Director

Sold 69 shares ($11K)

14 Oct 2026 144
13 Oct 2026 Form 4: Azar Alex M Ii, Director

Received 137 shares by exercise or conversion

02 Oct 2026 Form 4: Saia John G., Chief Legal Officer

Received 7,063 shares by exercise or conversion · Gave up 3,706 shares to cover exercise price or tax ($648K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support